Table 2. Raw and permuted P-values from family-based association tests using the VAS-P score and the severity of symptoms derived using latent class analyses, as qualitative and quantitative traits, respectively.
Marker | Gene | Allele | Frequency | Effect |
Score |
Severity |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inattention | H/I | ODD | CD | A/D | Inattention | H/I | ODD | A/D | |||||
Chromosome 4 | |||||||||||||
rs1947275 | LPHN3 | C | 0.814 | + | 0.00819a | ||||||||
rs2132074 | LPHN3 | G | 0.618 | + | 0.0017a | ||||||||
rs4552500 | LPHN3 | G | 0.608 | + | 0.0031b | ||||||||
rs13124636 | LPHN3 | G | 0.046 | − | 0.0414b | ||||||||
rs4860091 | LPHN3 | T | 0.386 | + | 0.0054b | ||||||||
rs335322 | LPHN3 | G | 0.575 | + | 0.007b | ||||||||
rs10015239 | LPHN3 | A | 0.577 | + | 0.0098b | ||||||||
rs35106420 | LPHN3 | G | 0.985 | + | 0.0154b | ||||||||
rs12646895 | LPHN3 | G | 0.508 | + | 0.0019b | ||||||||
rs1510920 | LPHN3 | C | 0.061 | + | 0.0368b | ||||||||
rs186750 | LPHN3 | A | 0.243 | + | 0.0216b | ||||||||
rs734644 | LPHN3 | T | 0.271 | + | 0.0117b | ||||||||
rs6813183 | LPHN3 | G | 0.300 | + | 0.0114b | ||||||||
rs6551670 | LPHN3 | A | 0.300 | + | 0.0105b | ||||||||
rs6551669 | LPHN3 | C | 0.300 | + | 0.0105b | ||||||||
Chromosome 5 | |||||||||||||
rs249637 | NDFIP1 | G | 0.074 | − | 0.0216b | ||||||||
rs37022 | SLC6A3 | T | 0.831 | + | 0.0052a | ||||||||
rs250682 | SLC6A3 | C | 0.798 | + | 0.0082b | ||||||||
rs6596271 | SLC25A48 | G | 0.042 | − | 0.0052b | ||||||||
rs164080 | GNPDA1 | C | 0.526 | + | 0.0015b | ||||||||
Chromosome 11 | |||||||||||||
rs10891551 | DRD2 | A | 0.122 | + | 0.0253b | ||||||||
rs719804 | TTC12 | G | 0.223 | − | 0.0117b | ||||||||
rs4938006 | NCAM1/TTC12 | G | 0.109 | + | 0.034b | 0.0106a | 0.0359a,c | ||||||
rs12799083 | DRD2 | C | 0.031 | − | 0.0107b | ||||||||
rs4245148 | DRD2 | T | 0.122 | + | 0.0251b | ||||||||
rs17596017 | NCAM1 | T | 0.024 | − | 0.0191b | ||||||||
rs1381246 | BSX | C | 0.451 | − | 0.0057b | ||||||||
rs652285 | NCAM1 | T | 0.057 | + | 0.0097b | 0.0082b | 0.0214b | ||||||
rs675646 | NCAM1 | C | 0.071 | + | 0.0107b | 0.0807b | 0.0105a | ||||||
rs649568 | NCAM1 | T | 0.044 | + | 0.0171b | 0.0162b | |||||||
rs702966 | PHRF1 | C | 0.276 | − | 0.0121b | ||||||||
rs2574829 | NCAM1 | G | 0.394 | + | 0.0084b | ||||||||
rs11214521 | NCAM1 | G | 0.035 | − | 0.0226 | ||||||||
rs11214505 | NCAM1 | G | 0.082 | − | 0.0292 | ||||||||
rs1055076 | TTC12 | A | 0.175 | + | 0.0343 | ||||||||
rs12222469 | NCAM1 | A | 0.035 | + | 0.0183b | ||||||||
Chromosome 12 | |||||||||||||
rs17722134 | TPH2 | G | 0.029 | − | 0.0085b | ||||||||
Chromosome 17 | |||||||||||||
rs7208257 | ARRB2 | C | 0.055 | + | 0.0164b |
Abbreviations: A/D, anxiety and depression; CD, conduct disorder; H/I, hyperactivity/impulsivity; ODD, oppositional defiant disorder; VAS-P, Vanderbilt Assessment Scale for Parents.
Nonsignificant P-values after B=10,000 permutations are shown in italic.
No correction for the number of questions interrogated was performed in genetic association analyses.
Permutated P-value <0.01.
Permutated P-value <0.05.
Effect on the severity towards opposite direction to the one described in the ‘effect' column.